Literature DB >> 15670976

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.

Joël LeMaoult1, Kamélia Zafaranloo, Caroline Le Danff, Edgardo D Carosella.   

Abstract

The nonclassical HLA class I antigen HLA-G is an inhibitory molecule involved in immune tolerance and immune escape. HLA-G exerts its inhibitory functions via interaction with inhibitory receptors ILT2, ILT4, and KIR2DL4, differentially expressed by NK, T, and antigen-presenting cells. Cells expressing HLA-G and cells expressing its receptors are often found in the vicinity of each other, but the mechanisms responsible for this colocalization are still unknown. We report that ILT2, ILT3, ILT4, and KIR2DL4 expression is up-regulated by HLA-G in antigen-presenting cells, NK cells, and T cells. Because this up-regulation seems not to require antigenic costimulation, it might precede an immune response. Functionally, up-regulation of inhibitory receptors in immune cells before stimulation might increase their activation thresholds and participate in immune escape mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670976     DOI: 10.1096/fj.04-1617fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  99 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 2.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 3.  Nanoparticles targeting HLA-G for gene therapy in cancer.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

4.  Proteomic analysis of knock-down HLA-G in invasion of human trophoblast cell line JEG-3.

Authors:  Haiyan Liu; Xueyuan Liu; Hong Jin; Fengying Yang; Weirong Gu; Xiaotian Li
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

5.  Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts.

Authors:  Madhu Chauhan; Meena Balakrishnan; Uma Yallampalli; Janice Endsley; Gary D V Hankins; Regan Theiler; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2011-08-03       Impact factor: 4.285

Review 6.  Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.

Authors:  Ênio José Bassi; Danilo Candido de Almeida; Pedro Manoel Mendes Moraes-Vieira; Niels Olsen Saraiva Câmara
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

7.  The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation.

Authors:  Monika Biedroń; Justyna Rybka; Tomasz Wróbel; Iwona Prajs; Rafał Poręba; Kazimierz Kuliczkowski
Journal:  Med Oncol       Date:  2015-07-18       Impact factor: 3.064

Review 8.  HLA class Ib in pregnancy and pregnancy-related disorders.

Authors:  Gry Persson; Wenna Nascimento Melsted; Line Lynge Nilsson; Thomas Vauvert F Hviid
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

Review 9.  Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection.

Authors:  Louise E Pilsbury; Rachel L Allen; Martin Vordermeier
Journal:  Mediators Inflamm       Date:  2010-06-20       Impact factor: 4.711

10.  HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker.

Authors:  Noura Alkhouly; Iman Shehata; Manal Basyouni Ahmed; Hanan Shehata; Sara Hassan; Tamer Ibrahim
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.